Posts From King World News

FDA again expands usage of Regeneron eye drug Eylea

(Reuters) – U.S. health regulators on Wednesday approved Regeneron Pharmaceuticals Inc’s big-selling eye drug Eylea to treat diabetic retinopathy, the most common diabetic eye disease and a leading cause of blindness in adults. The Food and Drug Administration decision marked the fourth approval for Eylea, an injectable medicine sold in partnership with French drugmaker Sanofi. “Today’s approval gives patients with diabetic retinopathy and diabetic macular edema another therapy to treat

Obamacare's Impact on Latino Access to Health Insurance

by Gabriel R. Sanchez, Francisco I. Pedraza and Edward D. Vargas As President Obama’s signature domestic policy achievement, the Affordable Care Act (ACA) faces another test in the upcoming Supreme Court case King v. Burwell. As we await a decision that has huge implications for Obamacare, we take a closer look at whether the ACA has been…

U.S. consumer safety regulators probes Lumber Liquidators laminates

WASHINGTON (Reuters) – The U.S. Consumer Product Safety Commission said on Wednesday it was investigating laminates used by Lumber Liquidators Holdings Inc, after reports that its products contained too-high levels of formaldehyde. Commission Chairman Elliot Kaye said the regulator would determine in the coming months whether the products were harmful to human health. He said the company had been cooperative so far with the agency’s probe. (Reporting by Emily Stephenson;

Fighters target vital water plants across Middle East: Red Cross

By Stephanie Nebehay GENEVA (Reuters) – Fighters are increasingly targeting water and sanitation facilities across the Middle East, exacerbating severe shortages for agriculture and households, the International Committee of the Red Cross (ICRC) said on Wednesday. Militants in Syria, Iraq and Gaza have also used access to water and electricity supplies as “tactical weapons or as bargaining chips,” the ICRC said in a report. “Heavy fighting and direct targeting have

New Ebola trial vaccine 'safe': researchers

The latest in a string of candidate vaccines against the deadly Ebola virus was proven safe in an early trial in healthy adults in China, its developers said Wednesday. Dubbed Ad5-EBOV, the vaccine is the first based on the strain of the Ebola virus behind the west African outbreak, according to a paper published in The Lancet medical journal. “Up to now, all tested Ebola virus vaccines have been based